107 related articles for article (PubMed ID: 33576604)
1. Multiple Applications of a Novel Biarsenical Imaging Probe in Fluorescence and PET Imaging of Melanoma.
Kondrashov M; Svensson SPS; Ström P; Westermark A; Jacobson-Ingemyr H; Takano A; Tari L; Tóth M; Cai M; Hruby VJ; Schou M
Bioconjug Chem; 2021 Mar; 32(3):497-501. PubMed ID: 33576604
[TBL] [Abstract][Full Text] [Related]
2. Radiofluorinated rhenium cyclized α-MSH analogues for PET imaging of melanocortin receptor 1.
Ren G; Liu S; Liu H; Miao Z; Cheng Z
Bioconjug Chem; 2010 Dec; 21(12):2355-60. PubMed ID: 21073170
[TBL] [Abstract][Full Text] [Related]
3. Preclinical evaluation of melanocortin-1 receptor (MC1-R) specific
Nagy G; Dénes N; Kis A; Szabó JP; Berényi E; Garai I; Bai P; Hajdu I; Szikra D; Trencsényi G
Eur J Pharm Sci; 2017 Aug; 106():336-344. PubMed ID: 28625749
[TBL] [Abstract][Full Text] [Related]
4. Small-animal PET of melanocortin 1 receptor expression using a 18F-labeled alpha-melanocyte-stimulating hormone analog.
Cheng Z; Zhang L; Graves E; Xiong Z; Dandekar M; Chen X; Gambhir SS
J Nucl Med; 2007 Jun; 48(6):987-94. PubMed ID: 17504880
[TBL] [Abstract][Full Text] [Related]
5. Melanoma Imaging Using
Zhang C; Zhang Z; Lin KS; Lau J; Zeisler J; Colpo N; Perrin DM; Bénard F
Mol Pharm; 2018 Jun; 15(6):2116-2122. PubMed ID: 29714486
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and characterization of a melanoma-targeted fluorescence imaging probe by conjugation of a melanocortin 1 receptor (MC1R) specific ligand.
Tafreshi NK; Huang X; Moberg VE; Barkey NM; Sondak VK; Tian H; Morse DL; Vagner J
Bioconjug Chem; 2012 Dec; 23(12):2451-9. PubMed ID: 23116461
[TBL] [Abstract][Full Text] [Related]
7. Melanocortin 1 Receptor Targeted Imaging of Melanoma With Gold Nanocages and Positron Emission Tomography.
Zhao Y; Pang B; Detering L; Luehmann H; Yang M; Black K; Sultan D; Xia Y; Liu Y
Mol Imaging; 2018; 17():1536012118775827. PubMed ID: 29873290
[TBL] [Abstract][Full Text] [Related]
8. Increasing molar activity by HPLC purification improves 68Ga-DOTA-NAPamide tumor accumulation in a B16/F1 melanoma xenograft model.
von Hacht JL; Erdmann S; Niederstadt L; Prasad S; Wagener A; Exner S; Beindorff N; Brenner W; Grötzinger C
PLoS One; 2019; 14(6):e0217883. PubMed ID: 31163066
[TBL] [Abstract][Full Text] [Related]
9. Imaging of melanoma using 64Cu- and 86Y-DOTA-ReCCMSH(Arg11), a cyclized peptide analogue of alpha-MSH.
McQuade P; Miao Y; Yoo J; Quinn TP; Welch MJ; Lewis JS
J Med Chem; 2005 Apr; 48(8):2985-92. PubMed ID: 15828837
[TBL] [Abstract][Full Text] [Related]
10. 64Cu-labeled alpha-melanocyte-stimulating hormone analog for microPET imaging of melanocortin 1 receptor expression.
Cheng Z; Xiong Z; Subbarayan M; Chen X; Gambhir SS
Bioconjug Chem; 2007; 18(3):765-72. PubMed ID: 17348700
[TBL] [Abstract][Full Text] [Related]
11. A gallium-labeled DOTA-alpha-melanocyte- stimulating hormone analog for PET imaging of melanoma metastases.
Froidevaux S; Calame-Christe M; Schuhmacher J; Tanner H; Saffrich R; Henze M; Eberle AN
J Nucl Med; 2004 Jan; 45(1):116-23. PubMed ID: 14734683
[TBL] [Abstract][Full Text] [Related]
12.
Yang J; Xu J; Gonzalez R; Lindner T; Kratochwil C; Miao Y
Sci Transl Med; 2018 Nov; 10(466):. PubMed ID: 30404861
[TBL] [Abstract][Full Text] [Related]
13. Al
Palangka CRAP; Hanaoka H; Yamaguchi A; Murakami T; Tsushima Y
Ann Nucl Med; 2019 Oct; 33(10):733-739. PubMed ID: 31297699
[TBL] [Abstract][Full Text] [Related]
14. A Conjugate of Pentamethine Cyanine and
An FF; Kommidi H; Chen N; Ting R
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28590411
[TBL] [Abstract][Full Text] [Related]
15.
Zhang C; Zhang Z; Merkens H; Zeisler J; Colpo N; Hundal-Jabal N; Perrin DM; Lin KS; Bénard F
Sci Rep; 2019 Sep; 9(1):13575. PubMed ID: 31537869
[TBL] [Abstract][Full Text] [Related]
16. Development of PEGylated peptide probes conjugated with (18)F-labeled BODIPY for PET/optical imaging of MT1-MMP activity.
Kondo N; Temma T; Deguchi J; Sano K; Ono M; Saji H
J Control Release; 2015 Dec; 220(Pt A):476-483. PubMed ID: 26578437
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis imaging probe predicts early chemotherapy response in preclinical models: A comparative study with 18F-FDG PET.
Song S; Xiong C; Lu W; Ku G; Huang G; Li C
J Nucl Med; 2013 Jan; 54(1):104-10. PubMed ID: 23283564
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, characterization and optimization of in vitro properties of NIR-fluorescent cyclic α-MSH peptides for melanoma imaging.
von Kiedrowski V; Hübner R; Kail D; Cheng X; Schirrmacher R; Wängler C; Wängler B
J Mater Chem B; 2020 Dec; 8(46):10602-10608. PubMed ID: 33136101
[TBL] [Abstract][Full Text] [Related]
19. In vivo and in silico pharmacokinetics and biodistribution of a melanocortin receptor 1 targeted agent in preclinical models of melanoma.
Tafreshi NK; Silva A; Estrella VC; McCardle TW; Chen T; Jeune-Smith Y; Lloyd MC; Enkemann SA; Smalley KS; Sondak VK; Vagner J; Morse DL
Mol Pharm; 2013 Aug; 10(8):3175-85. PubMed ID: 23763620
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of a targeted biarsenical Cy3-Cy5 affinity probe for super-resolution fluorescence imaging.
Fu N; Xiong Y; Squier TC
J Am Chem Soc; 2012 Nov; 134(45):18530-3. PubMed ID: 23116227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
